Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $156B | -$2.97B | 234 | 3.82% | Reduced |
|
| 2 |
BlackRock
New York
| $140B | -$3.03B | 256 | 4.02% | Reduced |
|
| 3 |
State Street
Boston,
Massachusetts
| $80.4B | -$2.77B | 230 | 4.46% | Reduced |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $33.9B | +$27.1M | 277 | 4.03% | Increased |
|
| 5 |
JP Morgan Chase
New York
| $33.8B | +$86.2M | 239 | 3.73% | Increased |
|
| 6 |
Fidelity Investments
Boston,
Massachusetts
| $30.2B | -$457M | 189 | 2.61% | Reduced |
|
| 7 |
Morgan Stanley
New York
| $29.6B | +$113M | 274 | 3.01% | Increased |
|
| 8 |
Wellington Management Group
Boston,
Massachusetts
| $29.4B | -$261M | 59 | 5.89% | Reduced |
|
| 9 |
Capital International Investors
Los Angeles,
California
| $22.4B | -$1.5B | 18 | 5.68% | Reduced |
|
| 10 |
T. Rowe Price Associates
Baltimore,
Maryland
| $21.1B | -$619M | 124 | 3.09% | Reduced |
|
| 11 |
Northern Trust
Chicago,
Illinois
| $20.4B | +$340M | 210 | 3.95% | Increased |
|
| 12 |
Capital World Investors
Los Angeles,
California
| $20.2B | -$2.97B | 17 | 4% | Reduced |
|
| 13 |
Norges Bank
Oslo,
Norway
| $18.5B | -$664M | 52 | 3.76% | Reduced |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $18.4B | -$288M | 238 | 2.02% | Reduced |
|
| 15 |
Charles Schwab
San Francisco,
California
| $18.3B | +$219M | 157 | 5.25% | Increased |
|
| 16 |
Bank of New York Mellon
New York
| $16.1B | -$560M | 166 | 3.54% | Reduced |
|
| 17 |
BBA
Baker Bros. Advisors
New York
| $14.4B | -$68.4M | 46 | 82.99% | Reduced |
|
| 18 |
Primecap Management
Pasadena,
California
| $13.1B | -$23M | 17 | 11.03% | Reduced |
|
| 19 |
Capital Research Global Investors
Los Angeles,
California
| $12.7B | -$473M | 15 | 3.5% | Reduced |
|
| 20 |
Legal & General Group
London,
United Kingdom
| $12.4B | -$596M | 134 | 4.32% | Reduced |
|
| 21 |
Goldman Sachs
New York
| $11.2B | +$513M | 163 | 2.39% | Increased |
|
| 22 |
Wells Fargo
San Francisco,
California
| $10.7B | -$490M | 260 | 3.12% | Reduced |
|
| 23 |
Dodge & Cox
San Francisco,
California
| $10.6B | -$272M | 12 | 7.12% | Reduced |
|
| 24 |
Invesco
Atlanta,
Georgia
| $10.5B | -$536M | 119 | 2.83% | Reduced |
|
| 25 |
Dimensional Fund Advisors
Austin,
Texas
| $9.95B | +$161M | 141 | 3.26% | Increased |
|